Trial Profile
A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisine in Adult Smokers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2021
Price :
$35
*
At a glance
- Drugs Cytisinicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms ORCA-1
- Sponsors Achieve Life Sciences
- 09 Nov 2021 According to an Achieve Life Sciences media release, analysis from this study were included in the SRNT-E annual meeting, held in September 2021.
- 13 Mar 2020 According to an Achieve Life Sciences media release, data from the study were presented at the Society for Research on Nicotine & Tobacco (SRNT) Annual Conference 2020.
- 12 Mar 2020 Results published in the Achieve Life Sciences Media Release.